Approval · Notice of Compliance 9861 · 2008
OLMETEC: Notice of Compliance 9861
Issued October 28, 2008
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 9861
- Date
- October 28, 2008
- Company
- Schering-Plough Canada Inc.Pointe-Claire, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Angiotensin ii at1 receptor blocker
Products in this notice
Medicinal ingredients
- OLMESARTAN MEDOXOMIL 20 MG per TAB
- OLMESARTAN MEDOXOMIL 40 MG per TAB
- OLMESARTAN MEDOXOMIL 5 MG per TAB